Accelerate Diagnostics Inc. Stock
Accelerate Diagnostics Inc. dominated the market today, gaining €0.065 (7.340%).
Pros and Cons of Accelerate Diagnostics Inc. in the next few years
Pros
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Accelerate Diagnostics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Accelerate Diagnostics Inc. | 7.340% | 15.152% | 18.012% | -85.606% | -73.611% | -98.348% | -99.433% |
MicroVision Inc | 1.330% | -7.397% | -18.378% | -71.294% | -57.371% | -90.531% | 56.029% |
Fonar Corp. New | - | -12.583% | -15.385% | -15.385% | -25.424% | -12.583% | -29.675% |
Allscripts Healthcare | - | 0.000% | -2.703% | -35.135% | -22.162% | -47.826% | -22.078% |
Comments
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for AXDX provided by MarketBeat
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for AXDX provided by MarketBeat